Complete PCI Better for Older MI Patients Too
AMSTERDAM — Complete revascularization improved outcomes over culprit-lesion-only stenting in older acute myocardial infarction (MI) patients, the FIRE trial affirmed. Among a population ages 75 and older, the composite risk of death, MI, stroke, or any revascularization came out a relative 27% less common when addressing all the stenosed vessels during the same hospitalization (15.7% […]
Immediate Complete Revascularization Non-Inferior to Staged Procedure
NEW ORLEANS – Immediate complete revascularization was non-inferior to staged complete revascularization in patients who presented with acute coronary syndrome (ACS) and multivessel disease, according to BIOVASC trial findings. In the prospective, open-label study, the composite primary outcome occurred in 7.6% of 764 patients in the immediate complete revascularization group and in 9.4% of 761 […]
Surgery Bests Endovascular Therapy for Most Limb-Threatening Ischemia Patients
CHICAGO — Surgical revascularization led to fewer major adverse limb events and deaths compared with endovascular therapy in patients with chronic limb-threatening ischemia, according to the prospective randomized BEST-CLI trial. After a median follow-up of 2.7 years, the primary composite outcome of major adverse limb events and death from any cause occurred in 42.6% of […]
PCI vs CABG: Does Age Inform Choice for Left Main Coronary Artery Disease?
BOSTON — Adding fuel to the controversy of revascularization for left main disease, patients had better survival after coronary artery bypass grafting (CABG) surgery than percutaneous coronary intervention (PCI) in an all-comers nationwide registry study. The incidence of all-cause mortality stayed greater up to 7 years after PCI versus CABG (adjusted HR 1.59, 95% CI […]
Paclitaxel Devices Safe in PAD In Medicare Data Beyond 3 Years
ATLANTA — Paclitaxel-coated devices for femoropopliteal artery revascularization were not associated with any excess mortality risk in the latest update from Medicare data. The risk of death from any cause, if anything, trended slightly lower (hazard ratio 0.98, 95% CI 0.96-0.99) with paclitaxel-eluting stents or -coated balloons compared with bare metal stent or percutaneous transluminal […]